Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Dexmedetomidine × Ethanol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Alcohol Drinking 8 Pancreatic Neoplasms 6 Neoplasms 5 Pancreatic Cyst 4 Cancer Pain 4 Agnosia 4 Smoking Cessation 3 Pain 3 Depression 3 Prostatic Neoplasms 2 Neoplasms, Cystic, Mucinous, and Serous 2 Multiple Endocrine Neoplasia Type 1 2 Lymphoma, Follicular 2 Lymphoma 2 Leukemia 2 Infections 2 Head and Neck Neoplasms 2 Condylomata Acuminata 2 Colorectal Neoplasms 2 Cardiovascular Diseases 2 Alcoholism 2 Wounds and Injuries 1 Warts 1 Waldenstrom Macroglobulinemia 1 Visceral Pain 1 Tuberculosis 1 Torulopsis 1 Tobacco Use Disorder 1 Thyroid Nodule 1 Thyroid Cancer, Papillary 1

Interventions

Dexmedetomidine 2 Saline Solution 1 Ethanol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05291364 2023-08-01

Dexmedetomidine in Splanchnic Nerve Neurolysis

Minia University

Phase NA Completed

Dexmedetomidine

Data powered by HemOnc (CC BY 4.0) Colophon ⚡